Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Siebler

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Neuroreport|June 19, 1998
TNF alpha induces a protein kinase C-dependent reduction in astroglial K+ conductanceH Köller, N Allert, D Oel, et al.
Neurology|April 1, 1994
Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid artery stenosisM Siebler, A Kleinschmidt, M Sitzer, et al.
Stroke|July 1, 1996
How good is intercenter agreement in the identification of embolic signals in carotid artery disease?H Markus, J M Bland, G Rose, et al.
Genes|September 23, 2022
DNA Polymerase ζ without the C-Terminus of Catalytic Subunit Rev3 Retains Characteristic Activity, but Alters Mutation Specificity of Ultraviolet Radiation in YeastHollie M Siebler, Jian Cui, Sarah E Hill, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 27, 2001
Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: an open pilot studyU Junghans, R J Seitz, A Aulich, et al.
Deutsche Medizinische Wochenschrift (1946)|February 23, 2002
[Long-term results after carotid reconstruction in patients with completed stroke caused by cerebrovascular occlusive disease]A Ommer, M Dziewanowski, M Pillny, et al.
Radiology|November 24, 2001
Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: report of four casesU Junghans, R J Seitz, H J Wittsack, et al.
Neuroepidemiology|August 14, 1998
Modifiable stroke risk factors in volunteers willing to participate in a prevention programM Sitzer, M Skutta, M Siebler, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 18, 2005
The pentapeptide QYNAD does not inhibit neuronal network activityF Otto, B C Kieseier, P Görtz, et al.
Synapse (New York, N.Y.)|July 1, 1993
Spontaneous activity and recurrent inhibition in cultured hippocampal networksM Siebler, H Köller, C C Stichel, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Neuroreport|June 19, 1998
TNF alpha induces a protein kinase C-dependent reduction in astroglial K+ conductanceH Köller, N Allert, D Oel, et al.
Neurology|April 1, 1994
Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid artery stenosisM Siebler, A Kleinschmidt, M Sitzer, et al.
Stroke|July 1, 1996
How good is intercenter agreement in the identification of embolic signals in carotid artery disease?H Markus, J M Bland, G Rose, et al.
Genes|September 23, 2022
DNA Polymerase ζ without the C-Terminus of Catalytic Subunit Rev3 Retains Characteristic Activity, but Alters Mutation Specificity of Ultraviolet Radiation in YeastHollie M Siebler, Jian Cui, Sarah E Hill, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 27, 2001
Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: an open pilot studyU Junghans, R J Seitz, A Aulich, et al.
Deutsche Medizinische Wochenschrift (1946)|February 23, 2002
[Long-term results after carotid reconstruction in patients with completed stroke caused by cerebrovascular occlusive disease]A Ommer, M Dziewanowski, M Pillny, et al.
Radiology|November 24, 2001
Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: report of four casesU Junghans, R J Seitz, H J Wittsack, et al.
Neuroepidemiology|August 14, 1998
Modifiable stroke risk factors in volunteers willing to participate in a prevention programM Sitzer, M Skutta, M Siebler, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 18, 2005
The pentapeptide QYNAD does not inhibit neuronal network activityF Otto, B C Kieseier, P Görtz, et al.
Synapse (New York, N.Y.)|July 1, 1993
Spontaneous activity and recurrent inhibition in cultured hippocampal networksM Siebler, H Köller, C C Stichel, et al.
Pageof 10